Plasma Therapy Market Growth, Size, Demand and Future Outlook 2027

Global Plasma Therapy Market by Type (Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, and Leukocyte-Rich Fibrin), By Source (Autologous, and Allogenic), By Application (Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others ), By End-User(Hospitals & Clinics and Research Institutes) and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa), Global Forecast to 2027

Global Plasma Therapy Market by Type (Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, and Leukocyte-Rich Fibrin), By Source (Autologous, and Allogenic), By Application (Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others ), By End-User(Hospitals & Clinics and Research Institutes) and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa), Global Forecast to 2027

Published: Apr 2020 Report ID: HLCA2006 Pages: 1 - 109 Formats*:     
Category : Healthcare
Global Plasma Therapy Market: Overview
Plasma therapy has a long history in the rehabilitation period. It has been more than 100 years to extract antibodies from animal plasma, but it has not been commonly used clinically in the past 50 or 60 years. It has used in the fight against the Ebola virus, and a few cases have been successful because there is no special effect medicine. Plasma therapy was discovered that the plasma of patients in the recovery period is sufficient for the treatment of diphtheria and tetanus. Those who have survived some infectious diseases and survived can develop immunity for a period of time, and sometimes even permanent immunity. It is also the basis of vaccine immunization. Plasma therapy was widely used in the first half of the twentieth century to treat various diseases, such as measles, mumps, pneumonia, shock, severe trauma, and other serious infections. When fighting SARS in 2003, many experts also adopted this treatment.

As an essential part of blood, the primary role of plasma is to transport the substances needed to maintain human life and the waste generated in the body. Plasma generally carries some important substances, including various antibodies, complement, coagulation factors, multiple ions, and nutrients, including amino acids, glucose, vitamins, albumin, and tumor markers. Plasma treatment is mainly used for cleaning, surface activation, deposition, and etching.



Global Plasma Therapy Market: Insights
The global plasma therapy market size was valued at USD 240.6 million in 2019 and is expected to generate USD 509.40 million, with a CAGR of 9.25% over the forecast period, 2020-2027. The growing incidences of trauma and increasing healthcare expenditure worldwide expected to propel the growth of the global plasma therapy in the future periods. Additionally, the rising geriatric population and growing orthopaedic conditions across the globe will spur the growth of the global plasma therapy market in the upcoming periods. Moreover, the surge in the use of platelet-rich plasma in various therapeutic areas is anticipated to drive the plasma therapy market in the analysis period.

Currently, the US Food and Drug Administration has paved the way for conduct clinical trials to test recovery in people at high risk of severe COVID-19 disease who have exposed to a virus test positive Phase plasma therapy. Plasma therapy in the recovery phase works best in the early stages of the disease. Currently, there is no proven drug therapy or effective vaccine for COVID-19.
Furthermore, the upsurge in the percentage of orthopaedic and sports injuries, rise in the number of cosmetic surgical procedures, along with the surge in adoption of platelet-rich plasma therapies in the treatment of various chronic diseases, are key factors projected to foster the global plasma therapy market in the forthcoming period. The growing population of chronic diabetes, such as diabetes, heart disease, cancer, and orthopaedic diseases coupled with the surge in investment by government and key players is estimated to promulgate the demand of the plasma therapy treatment in the forthcoming periods. Also, the growing usage of plasma therapy in the treatment of acute sports injuries, such as muscle injuries, acute ligament, and muscle injuries, surgery, knee arthritis, fractures, and pain will escalate the robust growth of the plasma therapy market in the estimated periods.
The SPER market research report of the Plasma Therapy market includes all integrated approaches to the growth of the market, along with an accurate & elaborate analysis of the complete competitive situation of this market on a global level. Besides the current analytical & statistical account, the report cloaks the trends market drivers, challenges, potential opportunities, which affect the market. This market report discusses the present situation to predicted trends & aspects of the growth of the Plasma Therapy market. Furthermore, it gives a dynamic overview & insights related to the market at both global as well as regional scales.

Global Plasma Therapy Market: Type Insight
Based on the type, the global plasma therapy market categorized into Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, and Leukocyte-Rich Fibrin. The Pure PRP segment accounted for a major market share in 2019, and it would continue by 2027, due to it eliminates red blood cells and neutrophils.
Leukocyte-Rich Fibrin segment will grow with a significant rate in the forecast period due to its help in improved healing response and significantly reduced recovery time.

Global Plasma Therapy Market: Source Insights
Based on the source, the global plasma therapy market bifurcated into Autologous and Allogenic. Autologous is likely to dominate the plasma therapy market by 2027, owing to the growing awareness regarding the benefits of plasma therapy, and it is used as a suitable remedy for the healing of bones and other tissues.

Global Plasma Therapy Market: Application Insights
Based on the application, the global plasma therapy market classified into Orthopaedic, Dermatology, cardiac Muscle Injury, Dental, Nerve Injury, and Others. The Orthopaedic segment anticipated dominating the market by 2027 due to the plasma therapy helps in the treatment of rotator cuff, quadriceps, hamstring, Achilles tendon injuries, and tennis elbow.

Global Plasma Therapy Market: End-User Insights
Based on the end-User, the global plasma therapy market categorized into Hospitals & Clinics and Research Institutes. The Text Analytics segment estimated to generate maximum revenue by 2027, on account of the surge in healthcare expenditure along with the rise in the use of plasma therapy in hospitals.

Global Plasma Therapy Market: Regional Insight
By geography, the global plasma therapy market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America will grow with a lucrative rate in the forecast period owing to the surge in the aging population and the increasing number of people suffering from orthopaedic disorders along with initiatives undertaken by the USA government to support developments in the field of plasma therapy.

The report presents a detailed assessment of the various factors influencing the market's trajectory into 2020 and 2027. It covers all the crucial information of the leading companies operating in the global Plasma Therapy market. Besides highlighting the product offerings, the report also calculates revenue generated over the period and their position in the market.

REPORT HIGHLIGHTS
  • Overview of key market forces restraining and propelling market growth.
  • Provide demand, current & past status & also the forecasting up to 2027.
  • Provide complete overview including, type, source, application, end-user & forecast region.
  • Provide focused analysis of key service providers with their market share & also help to identify market competition landscape with SWOT analysis.
  • Historical, current, and projected market size in terms of value.
  • Analyse the global & regional potential market, advantages, risk & opportunity.
  • Identify significant factors and trends driving or inhibiting the market growth.
  • In-depth coverage of the complete market in terms of supplier, buyer, price, trend, growth & forecasting.
THE REPORT COVERS ANALYSIS OF PLASMA THERAPY MARKET, BY TYPE
  • Pure PRP
  • Leukocyte-Rich PRP
  • Pure Platelet-Rich Fibrin
  • Leukocyte-Rich Fibrin
THE REPORT COVERS ANALYSIS OF PLASMA THERAPY MARKET, BY SOURCE
  • Autologous
  • Allogenic
THE REPORT COVERS ANALYSIS OF PLASMA THERAPY MARKET, BY APPLICATION
  • Orthopedic
  • Dermatology
  • Cardiac Muscle Injury
  • Dental
  • Nerve Injury
  • Others
THE REPORT COVERS ANALYSIS OF PLASMA THERAPY MARKET, BY END-USER
  • Hospitals & Clinics 
  • Research Institutes
THE REPORT COVERS EXHAUSTIVE ANALYSIS ON
  • Market Segments
  • Market Dynamics
  • Brands in Market
  • Market Size
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved
  • Forecasting
  • Technology
THE REPORT INCLUDES REGIONAL ANALYSIS ON
  • North America (Canada, US, Mexico, & Rest of North America Available)
  • Asia-Pacific (China, India, South Korea, Japan & Rest of Asia Pacific Available)
  • Europe (Germany, Spain, France, United Kingdom & Rest of Europe Available)
  • Central & South America (Brazil, Argentina & Rest of South America Available)  
  • Middle East & Africa (GCC Countries, South Africa, & Rest of MEA available)
KEY PLAYERS OF PLASMA THERAPY MARKET
  • BioLife Plasma Services 
  • Cambryn Biologics LLC
  • Biotest
  • CSL Ltd.
  • Grifols International S.A.
  • Kedrion S.p.A. 
  • LFB S.A.
  • Bio Products Laboratory Ltd. (BPL) 
  • China Biologic Products, Inc.
  • Octapharma 
  • Other Prominent Players

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact of the Plasma Therapy Market
4.4. Market Trends

5. Global Plasma Therapy Market, By Type, 2021-2027 (USD Million)
5.1. Pure PRP
5.2. Leukocyte-Rich PRP
5.3. Pure Platelet-Rich Fibrin
5.4. Leukocyte-Rich Fibrin

6. Global Plasma Therapy Market, By Source, 2021-2027 (USD Million)
6.1. Autologous
6.2. Allogenic

7. Global Plasma Therapy Market, By Application, 2021-2027 (USD Million)
7.1. Orthopedic
7.2. Dermatology
7.3. Cardiac Muscle Injury
7.4. Dental
7.5. Nerve Injury
7.6. Others

8. Global Plasma Therapy Market, By End User, 2021-2027 (USD Million)
8.1. Hospitals & Clinics
8.2. Research Institutes

9. Global Plasma Therapy Market, By Geography, 2021-2027 (USD Million)
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. UK
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Latin America
9.4.2. Middle East & Africa

10. Competitive Landscape
10.1. Introduction
10.2. Market Share Analysis, By Key Players (2019)
10.3. Competitive Scenario 
10.3.1. Product Launches
10.3.2. Partnerships, Collaborations and Agreements
10.3.3. Acquisitions
10.3.4. Expansions
10.3.5. Other Developments

11. Company Profiles
11.1. Bio Products Laboratory Ltd.
11.2. BioLife Plasma Services
11.3. Biotest
11.4. Cambryn Biologics LLC
11.5. China Biologic Products, Inc.
11.6. CSL Ltd.
11.7. Grifols International S.A.
11.8. Kedrion S.p.A.
11.9. LFB
11.10. Octapharma

12. Appendix


SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3

Not able to find what you are looking for? Need customization in the existing report?
Click Here

Join Our SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB
SPER-PWC
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB
SPER-PWC

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Certificates
iso-1 iso-1 iso-1 ESOMAR
Secure Payments
SPER Payment Options
Contact HR

 [email protected]

 +91-742-898-5650